Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05051189 · ClinicalTrials.gov registry record · Early Phase 1
Effect of Opioids on Central Control of Ventilation in Children With Obstructive Sleep Apnea
A Early Phase 1 study, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 90
- Enrollment target
NCT05051189 is a Early Phase 1 study that has completed, run by Baylor College of Medicine. The registered enrollment target is 90 participants.
The verdict
NCT05051189, a Early Phase 1 study, has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 90 participants
- Enrollment target
Study Summary
Children OSA exhibit varying responses to opioids. It is unknown if the degree of intermittent hypoxemia results in different opioid sensitivity
Interventions
- DRUG Fentanyl Citrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2021-12-01 |
| Est. Completion | 2024-11-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05051189
The ClinicalTrials.gov registry entry for NCT05051189 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fentanyl Citrate is the first listed.
NCT05051189 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05051189 about?
NCT05051189 is a clinical study titled "Effect of Opioids on Central Control of Ventilation in Children With Obstructive Sleep Apnea". Children OSA exhibit varying responses to opioids. It is unknown if the degree of intermittent hypoxemia results in different opioid sensitivity
What is the current status of trial NCT05051189?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 90 participants. The study started on 2021-12-01. Estimated completion is 2024-11-01.
What interventions are being tested in trial NCT05051189?
The interventions under investigation include: Fentanyl Citrate (DRUG).
Who is sponsoring clinical trial NCT05051189?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.